q ye

q ye State Department’s disinformation office to close after funding nixed in NDAAA recent advisory from the United States Surgeon General has made it clear — parents and caregivers are burned out. In a 2023 poll of more than 3,100 American parents, nearly 50 per cent reported experiencing debilitating levels of stress most days. Other recent surveys from Canada and the U.S. also found between 20 to 30 per cent of parents are experiencing moderate to severe levels of anxiety that could warrant a clinical diagnosis. When the tasks of the holidays are piled onto this baseline stress, it’s easy to see how the “season of joy” may feel more like the “season of overwhelm.” How can both our society as a whole and parents as individuals dial back the pressure? Structural changes are essential. But scientific insights about child development can also help parents prioritize what matters most and shift how they respond to things that may otherwise trigger anxiety. What’s causing parent stress? Much of what is making parents stressed these days is structural in nature: things are more expensive, it’s hard to find affordable child care, parents are more isolated, work is taking up more of parents’ time and children’s engagement with ever-evolving technology brings a range of serious health and safety concerns . These factors disproportionately affect parents who experience poverty, racism, violence or trauma. Addressing them will require substantial political and cultural shifts . But there are smaller factors to tackle as well. Parents today have more access to information than ever before. It’s not just a pediatrician or family member they can turn to for advice, but endless blogs, forums and social media platforms. While online sources can build community and confidence, they can also contribute to information overload as panic headlines and contradictory advice often compound parents’ feelings of anxiety and being overwhelmed. These platforms also tend to showcase idyllic situations that lead parents to create unhelpful comparisons and unrealistic expectations, contributing to feelings of shame and guilt . To counteract these feelings, it’s helpful to remember a few things: children’s development is influenced by many things parents can’t control, there are many benefits to imperfect parenting and independent play and parent wellness matters more than most else. 1. It’s more than just parenting It’s common for people who haven’t experienced discrimination or unexpected challenges to attribute children’s behaviours and outcomes to parents’ choices and efforts. This is an example of “attribution bias,” a bias towards a particular kind of explanation . Developmental science helps dispel this bias by highlighting that children’s development is influenced by many factors other than parenting and beyond parents’ control. First among these is genetics. For example, twin studies have found that genetic factors explain 57-76 per cent of child/adolescent mental illness, 60-84 per cent of picky eating and 60-85 per cent of school achievement. Another is exposure to adverse or positive experiences , such as witnessing violence or being supported by friends and non-parental adults. These types of experiences have substantial effects on children’s physical and mental health. But they are inequitably distributed, based on factors such as income and race . There are big differences in children’s temperaments and how they respond to their environments . The same parenting strategy applied to two different children can lead to two very different outcomes, as you may have observed in siblings. This is why the next time you catch yourself feeling shame or judgment about a child’s behaviour, it’s important to remember parenting choices might not be to blame. 2. Parental imperfections are opportunities Psychologists and pediatricians often recommend certain parenting strategies to support children’s development. But rarely do these providers suggest parents must follow their advice 100 per cent of the time to achieve the desired effects. It’s what happens most of the time that matters. Even when parenting “imperfections” happen, like breaking routines or uncharacteristically snapping at children, they can be seen as opportunities. When “rupture” is followed up by “repair” in the form of acknowledgement, apologies, explanations and/or moments for restoring connection, it can benefit the parent-child attachment relationship and help children build their emotion-regulation skills. By using repair after the overwhelming moments that often happen during the holidays, parents can transform these moments from sources of shame to reasons for pride. 3. Benefits of independent play Over the past few decades, parents’ worries about children’s physical safety have grown , while children’s unsupervised play time has declined . Many parents are spending more time with their children , hovering or helicoptering over them rather than promoting independent play. No doubt, playing with the support of a responsive adult has many benefits for children’s learning and development . But when it comes to parent involvement in play, sometimes less is more. Research shows that unstructured play — play that isn’t organized by adults and doesn’t have defined goals — is a “ fundamental necessity ” for children’s well-being. Outdoor risky play has enormous benefits for children’s physical and mental health that outweigh many of the perceived safety risks. There are also many unique benefits of playing with peers for both academic and social skill development. With this in mind, if you are a parent who is regularly your child’s main playmate, it may be time to seek more opportunities to take a step back. The holidays can be a great time to start. 4. Parent well-being is paramount News and social media feeds are full of panic headlines that can make it seem that certain foods, toys or parenting habits are what make or break children’s life outcomes. It’s easy for parents consuming this media to feel anxious or even want to change their purchases or behaviours in response to every new study. But most headlines overstate the findings of weak studies or small effects. And if following the headlines comes at the cost of parental well-being, it could be doing more harm than good. This is because one of the most consistent and strongest predictors of children’s well-being is having safe, stable and nurturing relationships with caregivers — as both the Canadian and American Pediatric Societies have stated. Children need present and responsive caregivers more than they need any specific foods, presents or new parenting fads. This is why it may be worth considering what you can do to support yourself or other parents’ well-being this year. This could mean providing practical or social support to the parents around you or just making them feel heard and understood . With high parental stress , it’s more important than ever for everyone to replace judgment with empathy and advice with real support. And for parents, let’s try to distinguish what we can and can’t control, practise self-forgiveness in tough times, allow ourselves moments to do less and focus in on what matters most. It might help us experience more moments of joy in this holiday season and through all the seasons of parenthood. Nina Sokolovic has worked in several roles at non-profit and government organizations that support the well-being of children and parents, including her current as a Senior Policy Analyst in the Ontario Public Service. She previously received funding for her research from the Social Sciences and Humanities Research Council of Canada.Tahj Brooks shines in final home game as Texas Tech routs West Virginia 52-15Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Gophers football adds Nebraska wideout Malachi Coleman via portalThe judge ruling over Elon Musk’s ~$55 billion CEO pay package, which some Tesla shareholders claimed was obtained without following proper governance rules, has decided to reject Tesla’s attempt to reinstate it with a shareholder vote. Delaware Supreme Court could be next. In 2018, Tesla shareholders voted for Elon Musk to get a historic new CEO compensation package that could be worth $55 billion for the executive if Tesla achieved remarkable growth in valuation and profits, which it did. However, some shareholders argued that Musk unfairly secured this extremely generous compensation plan by misleading shareholders about the fact that the plan was being put together by an independent board and negotiated in good faith. They filed a complaint in court in Delaware. The case went to trial in 2022, but it took a long time for the judge to give her decision. Earlier this year, Delaware Chancery Court Chief Judge Kathleen St. J. McCormick sided with the shareholders after testimonies from everyone involved in the pay package negotiations, or lack of negotiations, and a thorough investigation of how it came about. She determined that Musk was in control of the board during the time it granted him the pay package while the board members who approved the package were also granted historically large compensations, which they ended up partly reimbursing as part of . McCormick found many governance irregularities, including the fact that the board members who supposedly negotiated the package were not independent of Musk, and even his personal lead on the compensation was his own divorce lawyer, who he had recently hired to be general counsel at Tesla. The judge rescinded the compensation package, which included over $50 billion worth of Tesla stock options that the CEO had yet to exercise. She asked Tesla to go back to the drawing board, renegotiate the pay package in good faith, and present it properly to shareholders. Instead, Tesla disagreed with the judge’s findings around governance issues and decided to present the same package while including the judge’s decision in the updated proposal and having Tesla’s shareholders vote on it again. In June, Tesla shareholders voted to reapprove the package, albeit at a lower percentage than the original vote. Tesla’s legal team believed the vote would “ratify” the compensation package and force the judge to vacate her decision to void the pay package. However, both Tesla’s lawyers and most corporate law scholars agreed that this would require a completely new way to address ratification. McCormick listened to both sides this August, and we were awaiting her decision by the end of the year. Today, the judge released her decision and she sided against Tesla’s argument again: “The large and talented group of defense firms got creative with the ratification argument, but their unprecedented theories go against multiple strains of settled law.” Beyond the ratification problem, the judge also said that she believes Tesla again misrepresented the situation to shareholders in the statements made around the new vote: “Even if a stockholder vote could have a ratifying effect, it could not do so here due to multiple, material misstatements in the proxy statement.” On top of her ruling on the compensation, she also ruled against the lawyers for the shareholders, who were asking for a ridiculous $5 billion in Tesla stock as their legal fee. Instead, she awarded them $345 million. Tesla is likely to contest the ruling, which could move the case to the Delaware Supreme Court. As I wrote last summer, . Even if you believe Musk deserves this package, Tesla’s approach to reinstating it was boneheaded and didn’t follow the law as I, and seemingly the judge and most Delaware corporate law experts, understand it. Tesla, and more specifically Elon Musk, it’s hard to differentiate the two lately, which is part of the problem, are showing no intention to address their governance issues. Let’s be clear: Elon could get paid somewhat easily here. Even as much or close to this amount. However, it needs to do it through the proper governance and respect the process. Instead, Elon prefers to lie to shareholders and present the situation as politically motivated lawfare. It’s nonsense. and subscribe to the . Tesla is a transportation and energy company. It... Fred is the Editor in Chief and Main Writer at Electrek. You can send tips on Twitter (DMs open) or via email: fred@9to5mac.com Through Zalkon.com, you can check out Fred’s portfolio and get monthly green stock investment ideas. Get interesting investment ideas by Fred Lambert ChargePoint Home WiFi Enabled Electric Vehicle (EV) Charger

While there was high drama in Alexandra Palace on the first day back after the Christmas break, where Damon Heta threw a nine-dart finish, Humphries enjoyed a serene evening. He beat Nick Kenny 4-0 to set up a mouth-watering fourth-round meeting with two-time champion Peter Wright. THE WORLD NUMBER ONE KICKS ON! Luke Humphries comfortably books his spot in the Last 16 with a 4-0 whitewash victory over Nick Kenny, averaging 98.59! 📺 https://t.co/pIQvhqYxEj #WCDarts pic.twitter.com/XAADalXD4Q — PDC Darts (@OfficialPDC) December 27, 2024 Kenny was unable to produce the form that saw him beat Raymond van Barneveld in the previous round and Humphries did not need to be anywhere near his best. “It was one of those games I didn’t want to take for granted,” he said. “I expected a tough game and I wasn’t firing, I felt there is so much more to give, I felt there was more to come out of me. “I didn’t want to give anyone an inch because they can take a mile. “I’m not going to give up this world title without a fight, I wasn’t at my best but when someone pushes me I know I can come up with the goods.” Earlier in the day Heta set the tournament alight on its resumption with a stunning nine-dart finish before bowing out. The Australian, seeded ninth, achieved darting perfection in the second set of his match with Luke Woodhouse to earn a cool £60,000 payday. However, his joy was short-lived as Woodhouse won a thrilling battle 4-3, having trailed 3-1. HEROIC HETA HITS THE NINE! 🔥 UNBELIEVABLE SCENES! 🤯 Damon Heta lands the second nine-darter of the tournament to raise the roof at Alexandra Palace! #WCDarts pic.twitter.com/DW6rhvFqez — PDC Darts (@OfficialPDC) December 27, 2024 Heta was millimetres away from throwing a nine-darter in the previous round when he missed the double 12, but he made no mistake this time in the first match after the Christmas break. Heta’s feat was the second time a nine-darter has been thrown in the 2025 tournament and the 16th of all time at the World Championship, following Christian Kist’s effort before Christmas. As well as landing the Australian a hefty payday, it also saw a lucky fan in Ally Pally win a £60,000, with £60,000 also being donated to Prostate Cancer UK. There were several other titanic battles, none better than Gerwyn Price’s sudden-death leg victory over Joe Cullen. Price looked like he was going to have an easy night when he coasted into a 3-0 lead, but Cullen hit back to send it to a decider, which went all the way. Cullen landed a ‘Big Fish’ 170 checkout to send the tie to a sudden-death leg on his throw but Price hit some big numbers to steal victory. “That was tough, I just wanted to get over the winning line,” he said during his on-stage interview. PRICE WINS A THRILLER! That might just be the game of the tournament so far! 💥 Gerwyn Price manages to break the Rockstars throw in the final leg of the game, and beats Joe Cullen 4-3 and books his place in the Last 16! 📺 https://t.co/pIQvhqYxEj #WCDarts pic.twitter.com/VnjnJxP0T0 — PDC Darts (@OfficialPDC) December 27, 2024 “He kept coming back, the crowd were way behind him. “I thought I was going to lose, but I kept in there right to the end and got the win. “He played some good darts at the right times. I put myself in that position, I got myself out of it and I’m still in.” Seventh seed Jonny Clayton also battled to victory after squandering a 3-0 lead against Daryl Gurney. Gurney then had six darts to send the decider to a tiebreaker but lost his nerve and Clayton stole a 4-3 win. Stephen Bunting and Peter Wright, who was suffering from a chest infection, enjoyed much more safe passages with routine wins over Madars Razma and Jermaine Wattimena respectively.

Several times following New England’s 24-21 loss to the Buffalo Bills, Patriots coach Jerod Mayo said he wanted to review the game film before making a final assessment of his team’s performance. He did, and on Monday he said the overarching feeling he was left with was one of pride. Going toe-to-toe with one of the best teams in the NFL is commendable. Mayo also remains confident this group has even more room for growth over its final two games this season. “To be frank, I don’t believe in good losses,” Mayo said. “I think there’s a lot to learn from the game. Look, we’re headed in the right direction, but it’s all about consistency, and we have to do that on a down-after-down, a game-after-game basis to be successful in this league.” What is also clear is that despite their 3-12 record, Patriots rookie quarterback Drake Maye wants people to know that he and his teammates believe in their coach. No matter what conversations might be going on outside the Patriots locker room regarding shortcomings by the coaching staff, or Mayo’s job status. “We’ve got his back, and he’s coached us hard. He wants to win. We all want to win. We’re all frustrated,” Maye said. “We’re just plays away, and it’s basically me turning the ball over. I think it’s just a testament to these guys that keep fighting. We keep fighting. Shoot, we’re not going to make the playoffs; we’re out of the race, and these guys are coming in, frustrated when we don’t score. ... So, I think we’re building something good, building something that feels right here, and I’m proud to be a Patriot.” The Patriots entered the week scoring only 7.5 points per game in the first half this season, which ranked 29th in the NFL. The offense woke up with 14 points in the first half on Sunday, notching multiple offensive touchdowns in the first half for the first time in 2024. Stopping the run has been an issue for New England’s defense for most of the season and it was on display against the Bills. With Buffalo trailing 14-0 in the second quarter, running back James Cook sliced through the interior of the Patriots defense and broke free for a 46-yard TD run. It was a big chunk of Buffalo’s 172 yards on the ground for the game. CB Jonathan Jones. He was tasked with being the primary defender on Buffalo’s top receiver Khalil Shakir for most of the game. The veteran held his own, helping limit the Bills’ leader in catches and receiving yards to only two catches for 22 yards on six targets. Jones also forced a fumble by Shakir in the fourth quarter, though Shakir was able to recover it. Marte Mapu. The linebacker started at safety with Jabrill Peppers sidelined with a hamstring injury. Mapu was strong for most of the game and had a chance to set up the Patriots offense in the second quarter when he snagged his second career interception, picking off Josh Allen’s pass in the end zone. But Mapu decided to run the ball out of the end zone and was tackled on the New England 1-yard line. The poor starting field position eventually led to a punt and the Patriots couldn’t add to their 14-7 lead. The Patriots didn’t announce any injuries during the game. But along with Peppers, cornerback Marcus Jones also sat out with a hip injury. 2-6 — The Patriots’ record in one-score games this season. Four of those have been by three or fewer points. The Patriots host the Los Angeles Chargers on Saturday. AP NFL: https://apnews.com/hub/nfl

As a participant in multiple affiliate marketing programs, Localish will earn a commission for certain purchases. See full disclaimer below* Whether you're looking to upgrade your next movie night setup or hoping to game with higher-quality graphics, Cyber Monday is a great time to get the best TVs for a lower price. We rounded up some of the biggest sales going on right now to help you save on your next TV purchase. Best Cyber Monday TV deals for 2024 Insignia 32-inch Fire TV This TV is a great option for your living room, bedroom or office. Measuring 32 inches, it's decently sized, yet still easy to fit on a table or TV stand. It's also an Amazon Fire TV, so you'll have access to a wide variety of channels and apps. Currently, you can get it for under $100 at 46% off. TCL 40-inch Roku TV This TV has been rated five stars over 30,000 times on Amazon, and it's currently on sale for 27% off. It's compatible with both Alexa and Google Assistant and since it's a Roku TV, you'll have access to tons of channels and apps. Amazon 43-inch Fire TV You can get this great Fire TV for 38% off. It's compatible with 4K Ultra HD, Dolby Digital Plus and Alexa Voice. Amazon is also offering six months free of an MGM+ subscription with the purchase of this TV. Insignia 50-inch Fire TV This 4K Ultra HD TV is an Amazon bestseller and is currently on sale for 37% off. Enjoy high-quality resolution and a large screen size. This TV also comes with Alexa voice, so you can easily speak commands into the remote. SAMSUNG 85 Class DU7200B Crystal UHD 4K Smart TV This 85-inch TV is perfect for larger rooms and offers 4K resolution and accurate color representation thanks to Samsung's PurColor technology. Shop it now below $1,000. Toshiba 75-inch Fire TV If you're looking for a larger TV, this Toshiba 75-inch is a great deal. It boasts 4K resolution and both Dolby Vision HDR and Dolby Atmos. Save $200 on this TV for Cyber Monday. Amazon 75-inch Fire TV Enjoy cinematic 4K TV quality with this 75-inch Amazon Fire TV, which comes with Dolby Vision and Alexa voice control. Hisense 100-inch TV If you're looking for a large family room TV, this deal is a steal. Get this 100-inch Hisense TV for over $1,000 off right now. Both the QLED display technology and advanced full array local dimming bring you a high-quality viewing experience. Plus, this TV is also compatible with Alexa and Google Assistant. More TV deals below: Amazon 50-inch Fire TV for under $300. SAMSUNG 55-inch Class DU6900 Crystal UHD 4K Smart TV for under $300. LG 43-inch Class 4K UHD 2160P webOS Smart TV for just $350. *By clicking on the featured links, visitors will leave Localish.com and be directed to third-party e-commerce sites that operate under different terms and privacy policies. Although we are sharing our personal opinions of these products with you, Localish is not endorsing these products. It has not performed product safety testing on any of these products, did not manufacture them, and is not selling, or distributing them and is not making any representations about the safety or caliber of these products. Prices and availability are subject to change from the date of publication.

Tahj Brooks shines in final home game as Texas Tech routs West Virginia 52-15

(Reuters) – Microchip Technology lowered its third-quarter revenue forecast on Monday and announced the closure of its wafer manufacturing factory in Arizona, as the chipmaker looks to restructure under interim CEO Steve Sanghi. Microchip has been through a tumultuous few quarters, grappling with slowing orders for its automotive chips as carmakers, navigating an uncertain macro economy, clear existing inventory which they built up to avoid a supply crunch. The company now expects revenue to be close to the lower end of its previous forecast of $1.03 billion, below analysts’ expectations of $1.06 billion as per data compiled by LSEG. Shares of Microchip fell over 3.5% in extended trading after being around 3% higher at close. The company’s stock has fallen 22% so far this year. Microchip expects to shut down the Arizona facility in the September 2025 quarter and generate annual cash savings of around $90 million. “With inventory levels high and having ample capacity in place, we have decided to shut down our Tempe wafer fabrication facility that we refer to as Fab 2,” said interim CEO Sanghi, who came into the role after Ganesh Moorthy retired from the top job at the end of November. The company said the closure should help the company moderate its inventory levels beginning in the fourth quarter and will affect around 500 employees. The company said that its other factories in Oregon and Colorado have ample space for expansion and plans to transition product manufacturing from the Arizona plant to other such facilities. (Reporting by Zaheer Kachwala in Bengaluru; Editing by Krishna Chandra Eluri) Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content. var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );

CRANFORD, N.J. , Dec. 27, 2024 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported business and financial results for the fiscal full year ended September 30, 2024 . Fiscal Full Year 2024 Business Highlights and Subsequent Developments Financial Highlights "Reflecting on 2024, Citius Oncology has achieved pivotal milestones that underscore our commitment to advancing cancer therapeutics," stated Leonard Mazur , Chairman and CEO of Citius Oncology. "The FDA's approval of LYMPHIR for the treatment of cutaneous T-cell lymphoma marks a significant advancement in providing new options for patients battling this challenging disease. It is the only targeted systemic therapy approved for CTCL patients since 2018 and the only therapy with a mechanism of action that targets the IL-2 receptor. Additionally, the successful merger forming Citius Oncology, now trading on Nasdaq under the ticker CTOR, strengthens our position in the oncology sector. We expect it to facilitate greater access to capital to fund LYMPHIR's launch and the Company's future growth. With a Phase I investigator-initiated clinical trial combining LYMPHIR with pembrolizumab demonstrating promising preliminary results, indicating potential for enhanced treatment efficacy in recurrent solid tumors, and preliminary results expected from a second investigator trial with CAR-T therapies in 2025, we remain excited about the potential of LYMPHIR as a combination immunotherapy." "These accomplishments reflect the dedication of our team and the trust of our investors. As we look ahead, we remain steadfast in our mission to develop innovative therapies that improve the lives of cancer patients worldwide," added Mazur. FULL YEAR 2024 FINANCIAL RESULTS: Research and Development (R&D) Expenses R&D expenses were $4.9 million for the full year ended September 30, 2024 , compared to $4.2 million for the full year ended September 30, 2023 . The increase reflects development activities completed for the resubmission of the Biologics License Application of LYMPHIR in January 2024 , which were associated with the complete response letter remediation. General and Administrative (G&A) Expenses G&A expenses were $8.1 million for the full year ended September 30, 2024 , compared to $5.9 million for the full year ended September 30, 2023 . The increase was primarily due to costs associated with pre-commercial and commercial launch activities of LYMPHIR including market research, marketing, distribution and drug product reimbursement from health plans and payers. Stock-based Compensation Expense For the full year ended September 30, 2024 , stock-based compensation expense was $7.5 million as compared to $2.0 million for the prior year. The primary reason for the $5.5 million increase was due to the amounts being realized over 12 months in the year ended September 30, 2024 , as compared to three months post-plan adoption in the year ended September 30, 2023 . Net loss Net loss was $21.1 million , or ($0.31) per share for the year ended September 30, 2024 , compared to a net loss of $12.7 million , or ($0.19) per share for the year ended September 30, 2023 . The $8.5 million increase in net loss was primarily due to the increase in our operating expenses. About Citius Oncology, Inc. Citius Oncology specialty is a biopharmaceutical company focused on developing and commercializing novel targeted oncology therapies. In August 2024 , its primary asset, LYMPHIR, was approved by the FDA for the treatment of adults with relapsed or refractory CTCL who had had at least one prior systemic therapy. Management estimates the initial market for LYMPHIR currently exceeds $400 million , is growing, and is underserved by existing therapies. Robust intellectual property protections that span orphan drug designation, complex technology, trade secrets and pending patents for immuno-oncology use as a combination therapy with checkpoint inhibitors would further support Citius Oncology's competitive positioning. Citius Oncology is a publicly traded subsidiary of Citius Pharmaceuticals. For more information, please visit www.citiusonc.com Forward-Looking Statements This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius Oncology. You can identify these statements by the fact that they use words such as "will," "anticipate," "estimate," "expect," "plan," "should," and "may" and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated, and, unless noted otherwise, that apply to Citius Oncology are: our ability to raise additional money to fund our operations for at least the next 12 months as a going concern; our ability to commercialize LYMPHIR and any of our other product candidates that may be approved by the FDA; the estimated markets for our product candidates and the acceptance thereof by any market; the ability of our product candidates to impact the quality of life of our target patient populations; our dependence on third-party suppliers; our ability to procure cGMP commercial-scale supply; risks related to research using our assets but conducted by third parties; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; market and other conditions; risks related to our growth strategy; patent and intellectual property matters; our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; government regulation; competition; as well as other risks described in our Securities and Exchange Commission ("SEC") filings. These risks have been and may be further impacted by any future public health risks. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business are described in detail in our SEC filings which are available on the SEC's website at www.sec.gov , including in Citius Oncology's Annual Report on Form 10-K for the year ended September 30, 2024 , filed with the SEC on December 27, 2024 , as updated by our subsequent filings with the SEC. These forward-looking statements speak only as of the date hereof, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. Investor Contact: Ilanit Allen ir@citiuspharma.com 908-967-6677 x113 Media Contact: STiR-communications Greg Salsburg Greg@STiR-communications.com -- Financial Tables Follow – CITIUS ONCOLOGY, INC. CONSOLIDATED BALANCE SHEETS SEPTEMBER 30, 2024 AND 2023 2024 2023 Current Assets: Cash and cash equivalents $ 112 $ — Inventory 8,268,766 — Prepaid expenses 2,700,000 7,734,895 Total Current Assets 10,968,878 7,734,895 Other Assets: In-process research and development 73,400,000 40,000,000 Total Other Assets 73,400,000 40,000,000 Total Assets $ 84,368,878 $ 47,734,895 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $ 3,711,622 $ 1,289,045 License payable 28,400,000 — Accrued expenses — 259,071 Due to related party 588,806 19,499,119 Total Current Liabilities 32,700,429 21,047,235 Deferred tax liability 1,728,000 1,152,000 Note payable to related party 3,800,111 — Total Liabilities 38,228,540 22,199,235 Stockholders' Equity: Preferred stock - $0.0001 par value; 10,000,000 shares authorized: no shares issued and outstanding — — Common stock - $0.0001 par value; 100,000,000; 71,552,402 and 67,500,000 shares issued and outstanding at September 30, 2024 and 2023, respectively 7,155 6,750 Additional paid-in capital 85,411,771 43,658,750 Accumulated deficit (39,278,587) (18,129,840) Total Stockholders' Equity 46,140,339 25,535,660 Total Liabilities and Stockholders' Equity $ 84,368,878 $ 47,734,895 CITIUS ONCOLOGY, INC. CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Revenues $ — $ — Operating Expenses: Research and development 4,925,001 4,240,451 General and administrative 8,148,929 5,915,290 Stock-based compensation – general and administrative 7,498,817 1,965,500 Total Operating Expenses 20,572,747 12,121,241 Loss before Income Taxes (20,572,747) (12,121,241) Income tax expense 576,000 576,000 Net Loss $ (21,148,747) $ (12,697,241) Net Loss Per Share – Basic and Diluted $ (0.31) $ (0.19) Weighted Average Common Shares Outstanding – Basic and Diluted 68,053,607 67,500,000 CITIUS ONCOLOGY, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Cash Flows From Operating Activities: Net loss $ (21,148,747) $ (12,697,241) Adjustments to reconcile net loss to net cash provided by operating activities: Stock-based compensation expense 7,498,817 1,965,500 Deferred income tax expense 576,000 576,000 Changes in operating assets and liabilities: Inventory (2,133,871) - Prepaid expenses (1,100,000) (5,044,713) Accounts payable 2,422,577 1,196,734 Accrued expenses (259,071) (801,754) Due to related party 14,270,648 14,805,474 Net Cash Provided By Operating Activities 126,353 - Cash Flows From Investing Activities: License payment (5,000,000) - Net Cash Used In Investing Activities (5,000,000) - Cash Flows From Financing Activities: Cash contributed by parent 3,827,944 - Merger, net (2,754,296) - Proceeds from issuance of note payable to related party 3,800,111 - Net Cash Provided By Financing Activities 4,873,759 - Net Change in Cash and Cash Equivalents 112 - Cash and Cash Equivalents – Beginning of Year - - Cash and Cash Equivalents – End of Year $ 112 $ - Supplemental Disclosures of Cash Flow Information and Non-cash Activities: IPR&D Milestones included in License Payable $ 28,400,000 $

CHICAGO — It took 32 seconds of national embarrassment for George McCaskey, Kevin Warren and Ryan Poles to finally concede what everyone else already knew. And even when the Chicago Bears brain trust decided they no longer could justify keeping Matt Eberflus as head coach of their team, they still waited until he conducted one more news conference — telling us everything was fine and he was preparing for next week’s game against the San Francisco 49ers — before they actually pulled the trigger. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.Bryce Thompson scored 17 points and achieved a milestone as Oklahoma State defeated Miami 80-74 on Friday afternoon in a Charleston Classic consolation game in Charleston, S.C. Thompson made 6-of-14 shots from the floor, surpassing 1,000 points for his career at Oklahoma State (4-1), which also got 15 points from Marchelus Avery. The Cowboys won in large part thanks to their impressive 3-point shooting (10-for-22, 45.5 percent). Oklahoma State backup guard Arturo Dean, a Miami native, posted eight points and one steal. He led the nation in steals last season while playing for Florida International. Miami (3-2) has lost two straight games in Charleston, failing to take a lead at any point. They will play on Sunday against either Nevada or VCU. The Hurricanes on Friday were led by Nijel Pack, who had a game-high 20 points. Brandon Johnson had a double-double for Miami with 12 points and 10 rebounds. Matthew Cleveland scored 11 points and Lynn Kidd and Paul Djobet added 10 points apiece for Miami. Miami, which fell behind 7-0 in Thursday's loss to Drake, got behind 9-0 on Friday as Abou Ousmane scored six of his eight points. Oklahoma State stretched its lead to 18 before settling for a 43-27 advantage at the break. Pack led all first-half scorers with 10 points, but Miami shot just 29.6 percent from the floor, including 3-of-13 on 3-pointers (23.1). Oklahoma State shot 48.4 percent, including 8-for-15 on 3-pointers (53.3 percent) before intermission. The Cowboys also had a 14-8 edge in paint points. In the second half, Miami closed its 20-point deficit to 55-42 with 12:12 left. Miami got a bit closer as two straight short jumpers by Kidd, trimming the deficit to 73-62 with 3:25 to play. The Hurricanes cut it to 77-70 on Pack's 3-pointer with 34 seconds remaining, but the Cowboys hit their free throws to close out the win. --Field Level Media

After lackluster spending at U.S. stores on a deals-heavy Black Friday, retailers are pulling out all the stops with steep promotions and discounts on their websites and apps to entice people to buy holiday gifts and other merchandise after the long Thanksgiving weekend. Retailers have been coaxing cautious U.S. shoppers on Cyber Monday — traditionally America’s biggest internet shopping day — with push notifications, emails and other ads touting heavily discounted cosmetics, electronics, toys, clothing and other products. With just 23 days before Christmas, the discounts this year have been deeper, with shoppers waiting for promotion-heavy days, experts have said. For instance, Target said it was offering 50% off thousands of items including video games, home decor and other technology items with a “two-day Cyber Monday” sale that started on Sunday. The moves follow a mixed holiday season so far, with muted spending in stores on key shopping days such as Black Friday. Sales at brick-and-mortar stores on Friday grew just 0.7% year over year, according to preliminary estimates by payments processor Mastercard. Meanwhile, data firm Facteus said sales were actually lower. Online, retailers like Walmart and Amazon have relied on generative AI customer service and search features to make it easier for shoppers to find products on websites and mobile apps. Pittsburgh, Pennsylvania, resident Cheyenne Berens, 29, has been using Amazon’s generative AI chatbot Rufus to track prices of baby merchandise and electronics this holiday season. Amazon launched Rufus in February to give customers product recommendations and details based on its entire catalog of merchandise. “I have found that using Rufus on Amazon has been extremely helpful in determining whether a ‘deal’ is actually a ‘deal’,” Berens said. She’s been tracking the fluctuating prices of a Pack ‘n’ Play portable playpen and waiting for the right time to buy. The price started at $90 before the holidays, briefly rose to $120 and dropped back to $90, she said. Caila Schwartz, director of consumer insights at Salesforce, a cloud-computing company that tracks global shopping data from more than 1.5 billion consumers, said that GenAI tools such as chatbots to answer online shoppers’ basic questions, such as queries about products, helped retailers protect their profit margins despite rising costs. On Saturday, retailers using GenAI tools for customer service saw a 15% higher purchase rate by users, according to estimates by Salesforce. Schwartz said the higher so-called conversion rate “is a game changer.” Spending online today in the United States is expected to reach $13.2 billion, 6% more than on Cyber Monday a year earlier, according to preliminary estimates from Adobe Inc. That outlay would follow the roughly $10.8 billion Americans spent online on Black Friday, according to Adobe. Traffic to retail sites from chatbots or shoppers clicking on a link to a website rose 1,800% from Black Friday through the weekend, Adobe said. With many Americans recently carrying more debt, many are using third-party “buy now, pay later” services, with spending on the services likely to approach $1 billion, according to projections by Adobe, which keeps track of devices that use its software to help power more than 1 trillion visits to U.S. retail sites.Stock market rises with Nvidia as bitcoin bursts above $99,000